Apr. 2, 2026
Assisted Reproductive Technology Market Set to Reach $6.02 Billion by 2030
Increasing demand for IVF, expanding fertility clinics, and innovation in reproductive technologies drive sustained growth at a 7.0% CAGR
Apr. 2, 2026
Office Ally Acquires Jopari Solutions to Expand Clearinghouse Network
The deal will allow Office Ally to offer more end-to-end electronic transaction processing services.
Apr. 2, 2026
PAVmed Appoints Industry Veteran Joseph Virgilio to Lead Relaunched Medical Device Portfolio
Virgilio to oversee development and commercialization of PAVmed's current and future medical device programs.
Apr. 2, 2026
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
The clinical-stage biopharmaceutical company will hold one-on-one investor meetings at the upcoming event in New York City.
Apr. 2, 2026
Harmony Biosciences Strengthens Executive Team and Board
Appoints Peter Anastasiou as Chief Operating Officer, adds Troy Ignelzi to Board, and nominates Geno J. Germano for election
Apr. 2, 2026
Plus Therapeutics Expands Reimbursement for CNSide® CSF Assay to 75 Million Covered Lives
New agreement with Highmark, a leading Blue Cross Blue Shield-affiliated payer, marks milestone in expanding patient access to the diagnostic test.
Apr. 2, 2026
Tanabe Pharma America Finalizes RADICAVA Transfer to Shionogi
Tanabe Pharma Remains Focused on Rare Disease Innovation and Unmet Patient Needs
Apr. 2, 2026
Adagene Reports Positive Full Year 2025 Results, Provides Corporate Update
Biotech company highlights progress of lead candidate muzastotug, plans for 2026 and beyond
Apr. 2, 2026
OpenEvidence and Tandem Partner to Streamline Evidence-Based Prescribing
The collaboration aims to improve patient access to medications through data-driven prior authorization processes.
Apr. 2, 2026
Rochester Medical Software Firm Raises $5M, Names New CEO
Ambient Clinical Analytics secures funding, appoints new leadership.
Apr. 2, 2026
restor3d Launches Aeros Modular Stem System
The new medical device is now available for commercial use after years of development.
Apr. 2, 2026
Telix Appoints David Gill as Non-Executive Director
Pharmaceutical company Telix names new board member with extensive industry experience.
Apr. 2, 2026
Bloomington Officials Reassure After Novo Workforce Cut
City leaders point to tight labor market as Novo Nordisk plans 400 job losses.
Apr. 1, 2026
Eli Lilly Acquires Contessa in $47.8B Deal
The blockbuster acquisition aims to bolster Eli Lilly's pharmaceutical dominance.
Apr. 1, 2026
Surgery Partners Expands Footprint with Acquisitions and De Novo Centers
The company has grown its network to over 200 ASCs across 33 states since 2022.
Apr. 1, 2026
Medline Earns Top Supply Chain Honors from Healthcare Industry Resiliency Collaborative
Medical supplier recognized for partnership, resiliency, and transparency in healthcare supply chain
Apr. 1, 2026
Cosmo Direct Supply Highlights Key Trends Shaping the Aesthetic Medicine Industry in 2026
Cosmo Direct Supply shares insights into the growing demand for minimally invasive procedures and a broadening demographic of individuals seeking non-surgical treatments.
Apr. 1, 2026
Janux Therapeutics Announces Development Candidate Nomination
Milestone payment of $35 million triggered under Bristol Myers Squibb collaboration
Apr. 1, 2026
Zentist Announces Dental RCM Bootcamp 6.0 in Nashville
The dental revenue cycle management company is bringing its popular training program to Tennessee.
Apr. 1, 2026
Orionis Biosciences Appoints Dr. Giulio Draetta as Chief Strategy Officer
Amid strong pipeline growth, the biotech firm strengthens its leadership team.
